Computers in Biology and Medicine · 2024 · 14 citations · 31 references
MedicineCardiologySurgeryComputational Fluid DynamicsFluid DynamicsInterventional CardiologyHemodynamicsHemodynamics ModelingPlatelet ActivationPlatelet AggregationPlatelet FunctionThrombosisAortic BiomechanicsCardiovascular Fluid-structure InteractionFluid-structure Interaction ModelingLagrangian Particle TrackingPlatelet Thrombus FormationThrombosis ModelingValve MechanicsValvular Hemodynamics
Transcatheter aortic heart valve thrombosis (THVT) affects long-term valve durability, transvalvular pressure gradient and leaflet mobility. In this study, we conduct high-fidelity fluid-structure interaction simulations to perform Lagrangian particle tracing in a generic model with larger aortic diameters (THVT model) with and without neo-sinus which is compared to a model of unaffected TAVI patients (control model). Platelet activation indices are computed for each particle to assess the risk of thrombus formation induced by high shear stresses followed by flow stagnation. Particle tracing indicates that fewer particles contribute to sinus washout of the THVT model with and without neo-sinus compared to the control model (-34.9%/-34.1%). Stagnating particles in the native sinus of the THVT model show higher platelet activation indices than for the control model (+39.6% without neo-sinus, +45.3% with neo-sinus). Highest activation indices are present for particles stagnating in the neo-sinus of the larger aorta representing THVT patients (+80.2% compared to control). This fluid-structure interaction (FSI) study suggests that larger aortas lead to less efficient sinus washout in combination with higher risk of platelet activation among stagnating particles, especially within the neo-sinus. This could explain (a) a higher occurrence of thrombus formation in transcatheter valves compared to surgical valves without neo-sinus and (b) the neo-sinus as the prevalent region for thrombi in TAV. Pre-procedural identification of larger aortic roots could contribute to better risk assessment of patients and improved selection of a patient-specific anti-coagulation therapy.
31
Transcatheter Aortic Valve Thrombosis
Nicolaj C. Hansson, Erik Lerkevang Grove, Henning Andersen et al. · Journal of the American College of Cardiology · 2016 · 360 citations
Medicine, Cardiology, Surgery +12
Treatment and Clinical Outcomes of Transcatheter Heart Valve Thrombosis
Azeem Latib, Toru Naganuma, Mohamed Abdel‐Wahab et al. · Circulation Cardiovascular Interventions · 2015 · 289 citations · Full text
Medicine, Cardiology, Surgery +15